Moreover, a different study has shown that recombinant human GLP-1 can reduce oxidative stress by activating PKA, which was found to be elevated in the study of Park et al. (2019), and by inhibiting PKC, which was found to be decreased, ultimately reversing diabetic nephropathy [161]. Here, GLP1R is linked to diabetic kidney disease.